lorazepam has been researched along with bromocriptine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Patkar, AA; Shah, LP | 1 |
| Raheja, R; Singerman, B | 1 |
| Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B | 1 |
| Leung, CM; Leung, WK; Tang, CP; Ungvari, GS | 1 |
| Jiloha, RC; Mendhekar, DN | 1 |
| Bildik, T; Ercan, ES; Erermis, S; Gockay, A; Karasoy, H; Tamar, M | 1 |
| Caroff, SN; Keck, PE; Strawn, JR | 1 |
| Fraile, S; García, B; Hidalgo, FJ; Lopez, E | 1 |
| Bc, M; Chatterjee, SS; Das, S; Kartha, A; Purushothaman, ST; Rajan, V | 1 |
| Barahona-Corrêa, JB; Neves, A; Oliveira-Maia, AJ; Velosa, A | 1 |
4 review(s) available for lorazepam and bromocriptine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Malignant catatonia--a continuing reality.
Topics: Adult; Aged; Antipsychotic Agents; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lorazepam; Male; Middle Aged | 1994 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors | 1996 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors | 2007 |
8 other study(ies) available for lorazepam and bromocriptine
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Neuroleptic malignant syndrome (a case report).
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome | 1991 |
The syndrome of lethal catatonia.
Topics: Adult; Bromocriptine; Catatonia; Diagnosis, Differential; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Lorazepam; Neurocognitive Disorders; Patient Care Team | 1995 |
Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome | 2005 |
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Topics: Adolescent; Anti-Anxiety Agents; Antidotes; Antipsychotic Agents; Bromocriptine; Clopenthixol; Delayed-Action Preparations; Diazepam; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lithium Compounds; Lorazepam; Neuroleptic Malignant Syndrome; Treatment Outcome | 2007 |
[Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine].
Topics: Antipsychotic Agents; Aripiprazole; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Frontotemporal Dementia; Humans; Imipramine; Lorazepam; Male; Mental Disorders; Middle Aged; Neuroleptic Malignant Syndrome; Oxygen Inhalation Therapy; Piperazines; Quinolones; Respiration, Artificial; Respiratory Insufficiency | 2013 |
Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dibenzocycloheptenes; Dopamine Agonists; Drug Overdose; Fluid Therapy; GABA Modulators; Heterocyclic Compounds, 4 or More Rings; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Valproic Acid | 2017 |
Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Female; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Renal Dialysis; Treatment Outcome | 2019 |